Search
for
Sort by
Research 30 of 1000+
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Breast Cancer-Related Neoplastic Alopecia: A Case Report and Review of the Literature
- A 3D microtumour system that faithfully represents ovarian cancer minimal residual disease
- Alopecia areata as a paraneoplastic syndrome of Hodgkin’s lymphoma: A case report
- Management of the adverse effects of targeted therapy for cancer
- Chemotherapy-induced alopecia: A novel observation
- DRUGS AND DEVICES IN PREVENTION AND TREATMENT OF CHEMOTHERAPY-INDUCED ALOPECIA: WHEN AND HOW SHOULD BE EMPLOYED
- Monitoring chemotherapy‐induced alopecia with trichoscopy
- Onychomatricoma with classic features: Case report and review of the literature
- Chemotherapy of psoriasis and other skin disorders with oral retinoids
- Oral Minoxidil for Chemotherapy-Induced Alopecia
- Pathobiology of chemotherapy-induced hair loss
- Impact of Chemotherapeutic Drug on People living with Cancer
- Periungual lesions secondary to chemotherapy with docetaxel
- Mucocutaneous reactions to chemotherapy
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- Prevention of Alopecia in Medical and Interventional Chemotherapy Patients
- Chemotherapy-Induced Eyebrow Alopecia and Psychological Recovery: Permanent Micropigmentation as a Component of Multidisciplinary Oncological Rehabilitation
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Clinical and histological study of permanent alopecia after bone marrow transplantation
- 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D3 analogue in humans
- Cancer Chemotherapy: an Introduction
- Folliculotropic mycosis fungoides
- 55-Year-Old Female with Alopecia of the Scalp and Body After Chemotherapy